|
1
|
Matos ADO, Dantas PHDS, Queiroz HAGDB, Silva-Sales M, Sales-Campos H. TREM-2: friend or foe in infectious diseases? Crit Rev Microbiol 2024; 50:1-19. [PMID: 36403150 DOI: 10.1080/1040841x.2022.2146481] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2022] [Accepted: 11/07/2022] [Indexed: 11/21/2022]
Abstract
The triggering receptor expressed on myeloid cells-2 (TREM-2) is an immune receptor expressed on immune and non-immune cells, more frequently investigated in neurodegenerative disorders and considered a marker for microglia activation. In infectious diseases, the receptor was initially believed to be an anti-inflammatory molecule, opposing the inflammation triggered by TREM-1. Currently, TREM-2 is associated with different aspects in response to infectious stimuli, including the induction of bacterial phagocytosis and clearance, containment of exacerbated pro-inflammatory responses, induction of M2 differentiation and activation of Th1 lymphocytes, besides of neurological damage after viral infection. Here, we present and discuss results published in the last two decades regarding the expression, activation and functions of TREM-2 during the course of bacterial, viral, fungal and parasitic infections. A surprisingly plasticity was observed regarding the roles of the receptor in the aforementioned contexts, which largely varied according to the cell/organ and pathogen type, besides influencing disease outcome. Therefore, our review aimed to critically overview the role of TREM-2 in infectious diseases, highlighting its potential to be used as a clinical biomarker or therapeutic target.
Collapse
Affiliation(s)
| | | | | | - Marcelle Silva-Sales
- Instituto de Patologia Tropical e Saúde Pública, Universidade Federal de Goiás, Goiânia, Brazil
| | | |
Collapse
|
|
2
|
Kollet O, Das A, Karamanos N, Auf dem Keller U, Sagi I. Redefining metalloproteases specificity through network proteolysis. Trends Mol Med 2024; 30:147-163. [PMID: 38036391 PMCID: PMC11004056 DOI: 10.1016/j.molmed.2023.11.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2023] [Revised: 10/18/2023] [Accepted: 11/02/2023] [Indexed: 12/02/2023]
Abstract
Proteolytic processes on cell surfaces and extracellular matrix (ECM) sustain cell behavior and tissue integrity in health and disease. Matrix metalloproteases (MMPs) and a disintegrin and metalloproteases (ADAMs) remodel cell microenvironments through irreversible proteolysis of ECM proteins and cell surface bioactive molecules. Pan-MMP inhibitors in inflammation and cancer clinical trials have encountered challenges due to promiscuous activities of MMPs. Systems biology advances revealed that MMPs initiate multifactorial proteolytic cascades, creating new substrates, activating or suppressing other MMPs, and generating signaling molecules. This review highlights the intricate network that underscores the role of MMPs beyond individual substrate-enzyme activities. Gaining insight into MMP function and tissue specificity is crucial for developing effective drug discovery strategies and novel therapeutics. This requires considering the dynamic cellular processes and consequences of network proteolysis.
Collapse
Affiliation(s)
- Orit Kollet
- The Weizmann Institute of Science, Department of Immunology and Regenerative Biology, Rehovot, Israel
| | - Alakesh Das
- The Weizmann Institute of Science, Department of Immunology and Regenerative Biology, Rehovot, Israel
| | - Nikos Karamanos
- University of Patras, Biochemistry, Biochemical Analysis and Matrix Pathobiology Research Group, Laboratory of Biochemistry, Department of Chemistry, Patras, Greece
| | - Ulrich Auf dem Keller
- Technical University of Denmark, Department of Biotechnology and Biomedicine, Lyngby, Denmark
| | - Irit Sagi
- The Weizmann Institute of Science, Department of Immunology and Regenerative Biology, Rehovot, Israel.
| |
Collapse
|
|
3
|
Cohen N, Vagima Y, Mouhadeb O, Toister E, Gutman H, Lazar S, Jayson A, Artzy-Schnirman A, Sznitman J, Ordentlich A, Yitzhaki S, Seliktar D, Mamroud E, Epstein E. PEG-fibrinogen hydrogel microspheres as a scaffold for therapeutic delivery of immune cells. Front Bioeng Biotechnol 2022; 10:905557. [PMID: 36017344 PMCID: PMC9395737 DOI: 10.3389/fbioe.2022.905557] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2022] [Accepted: 07/14/2022] [Indexed: 11/25/2022] Open
Abstract
Recent advances in the field of cell therapy have proposed new solutions for tissue repair and regeneration using various cell delivery approaches. Here we studied ex vivo a novel topical delivery system of encapsulated cells in hybrid polyethylene glycol-fibrinogen (PEG-Fb) hydrogel microspheres to respiratory tract models. We investigated basic parameters of cell encapsulation, delivery and release in conditions of inflamed and damaged lungs of bacterial-infected mice. The establishment of each step in the study was essential for the proof of concept. We demonstrated co-encapsulation of alveolar macrophages and epithelial cells that were highly viable and equally distributed inside the microspheres. We found that encapsulated macrophages exposed to bacterial endotoxin lipopolysaccharide preserved high viability and secreted moderate levels of TNFα, whereas non-encapsulated cells exhibited a burst TNFα secretion and reduced viability. LPS-exposed encapsulated macrophages exhibited elongated morphology and out-migration capability from microspheres. Microsphere degradation and cell release in inflamed lung environment was studied ex vivo by the incubation of encapsulated macrophages with lung extracts derived from intranasally infected mice with Yersinia pestis, demonstrating the potential in cell targeting and release in inflamed lungs. Finally, we demonstrated microsphere delivery to a multi-component airways-on-chip platform that mimic human nasal, bronchial and alveolar airways in serially connected compartments. This study demonstrates the feasibility in using hydrogel microspheres as an effective method for topical cell delivery to the lungs in the context of pulmonary damage and the need for tissue repair.
Collapse
Affiliation(s)
- Noam Cohen
- Israel Institute for Biological Research, Ness-Ziona, Israel
| | - Yaron Vagima
- Israel Institute for Biological Research, Ness-Ziona, Israel
- *Correspondence: Yaron Vagima, ; Eyal Epstein,
| | - Odelia Mouhadeb
- Israel Institute for Biological Research, Ness-Ziona, Israel
- Department of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa, Israel
| | - Einat Toister
- Israel Institute for Biological Research, Ness-Ziona, Israel
| | - Hila Gutman
- Israel Institute for Biological Research, Ness-Ziona, Israel
| | - Shlomi Lazar
- Israel Institute for Biological Research, Ness-Ziona, Israel
| | - Avital Jayson
- Israel Institute for Biological Research, Ness-Ziona, Israel
| | - Arbel Artzy-Schnirman
- Department of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa, Israel
| | - Josué Sznitman
- Department of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa, Israel
| | - Arie Ordentlich
- Israel Institute for Biological Research, Ness-Ziona, Israel
| | - Shmuel Yitzhaki
- Israel Institute for Biological Research, Ness-Ziona, Israel
| | - Dror Seliktar
- Department of Biomedical Engineering, Technion-Israel Institute of Technology, Haifa, Israel
| | | | - Eyal Epstein
- Israel Institute for Biological Research, Ness-Ziona, Israel
- *Correspondence: Yaron Vagima, ; Eyal Epstein,
| |
Collapse
|
|
4
|
Gutman H, Aftalion M, Melamed S, Politi B, Nevo R, Havusha-Laufer S, Achdout H, Gur D, Israely T, Dachir S, Mamroud E, Sagi I, Vagima Y. Matrix Metalloproteinases Expression Is Associated with SARS-CoV-2-Induced Lung Pathology and Extracellular-Matrix Remodeling in K18-hACE2 Mice. Viruses 2022; 14:1627. [PMID: 35893698 PMCID: PMC9332556 DOI: 10.3390/v14081627] [Citation(s) in RCA: 11] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2022] [Revised: 07/01/2022] [Accepted: 07/19/2022] [Indexed: 02/04/2023] Open
Abstract
The COVID-19 pandemic caused by the SARS-CoV-2 infection induced lung inflammation characterized by cytokine storm and fulminant immune response of both resident and migrated immune cells, accelerating alveolar damage. In this work we identified members of the matrix metalloprotease (MMPs) family associated with lung extra-cellular matrix (ECM) destruction using K18-hACE2-transgenic mice (K18-hACE2) infected intranasally with SARS-CoV-2. Five days post infection, the lungs exhibited overall alveolar damage of epithelial cells and massive leukocytes infiltration. A substantial pulmonary increase in MMP8, MMP9, and MMP14 in the lungs post SARS-CoV-2 infection was associated with degradation of ECM components including collagen, laminin, and proteoglycans. The process of tissue damage and ECM degradation during SARS-CoV-2 lung infection is suggested to be associated with activity of members of the MMPs family, which in turn may be used as a therapeutic intervention.
Collapse
Affiliation(s)
- Hila Gutman
- Israel Institute for Biological Research, Ness Ziona P.O. Box 19, Israel; (H.G.); (M.A.); (S.M.); (B.P.); (H.A.); (D.G.); (T.I.); (S.D.); (E.M.)
- Department of Biological Regulation, Weizmann Institute of Science, Herzel 234, Rehovot P.O. Box 26, Israel;
- Department of Biomolecular Sciences, Weizmann Institute of Science, Herzel 234, Rehovot P.O. Box 26, Israel;
| | - Moshe Aftalion
- Israel Institute for Biological Research, Ness Ziona P.O. Box 19, Israel; (H.G.); (M.A.); (S.M.); (B.P.); (H.A.); (D.G.); (T.I.); (S.D.); (E.M.)
| | - Sharon Melamed
- Israel Institute for Biological Research, Ness Ziona P.O. Box 19, Israel; (H.G.); (M.A.); (S.M.); (B.P.); (H.A.); (D.G.); (T.I.); (S.D.); (E.M.)
| | - Boaz Politi
- Israel Institute for Biological Research, Ness Ziona P.O. Box 19, Israel; (H.G.); (M.A.); (S.M.); (B.P.); (H.A.); (D.G.); (T.I.); (S.D.); (E.M.)
| | - Reinat Nevo
- Department of Biomolecular Sciences, Weizmann Institute of Science, Herzel 234, Rehovot P.O. Box 26, Israel;
| | - Sapir Havusha-Laufer
- Department of Biological Regulation, Weizmann Institute of Science, Herzel 234, Rehovot P.O. Box 26, Israel;
| | - Hagit Achdout
- Israel Institute for Biological Research, Ness Ziona P.O. Box 19, Israel; (H.G.); (M.A.); (S.M.); (B.P.); (H.A.); (D.G.); (T.I.); (S.D.); (E.M.)
| | - David Gur
- Israel Institute for Biological Research, Ness Ziona P.O. Box 19, Israel; (H.G.); (M.A.); (S.M.); (B.P.); (H.A.); (D.G.); (T.I.); (S.D.); (E.M.)
| | - Tomer Israely
- Israel Institute for Biological Research, Ness Ziona P.O. Box 19, Israel; (H.G.); (M.A.); (S.M.); (B.P.); (H.A.); (D.G.); (T.I.); (S.D.); (E.M.)
| | - Shlomit Dachir
- Israel Institute for Biological Research, Ness Ziona P.O. Box 19, Israel; (H.G.); (M.A.); (S.M.); (B.P.); (H.A.); (D.G.); (T.I.); (S.D.); (E.M.)
| | - Emanuelle Mamroud
- Israel Institute for Biological Research, Ness Ziona P.O. Box 19, Israel; (H.G.); (M.A.); (S.M.); (B.P.); (H.A.); (D.G.); (T.I.); (S.D.); (E.M.)
| | - Irit Sagi
- Department of Biological Regulation, Weizmann Institute of Science, Herzel 234, Rehovot P.O. Box 26, Israel;
| | - Yaron Vagima
- Israel Institute for Biological Research, Ness Ziona P.O. Box 19, Israel; (H.G.); (M.A.); (S.M.); (B.P.); (H.A.); (D.G.); (T.I.); (S.D.); (E.M.)
| |
Collapse
|